Proceedings: Alkaline sucrose gradient sedimentation studies of DNA synthesized in methyl-azoxymethanol acetate treated HeLa cells.

por Van den Berg, H. W.
Publicado 1974

Different impact of factor VIII products on inhibitor development?

por van den Berg, H. Marijke
Publicado 2016

Proceedings: Synergism between the anti-tumour agent cis platinum (II) diamminedichloride and caffeine: toxicological and molecular studies.

por van den Berg, H. W., Roberts, J. J.
Publicado 1975

Unraveling the secrets of white matter – Bridging the gap between cellular, animal and human imaging studies

por Walhovd, K.B., Johansen-Berg, H., Káradóttir, R.T.
Publicado 2014

High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.

por van den Berg, H. W., Martin, J., Lynch, M.
Publicado 1990

Quality of life following road traffic injury: the impact of age and gender

por Rissanen, R., Ifver, J., Hasselberg, M., Berg, H.-Y.
Publicado 2020

Osteosarcoma: A Comparison of Jaw versus Nonjaw Localizations and Review of the Literature

por van den Berg, H., Schreuder, W. H., de Lange, J.
Publicado 2013

Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.

por Clarke, R., Van den Berg, H. W., Kennedy, D. G., Murphy, R. F.
Publicado 1985

Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast ca...

por Long, B., McKibben, B. M., Lynch, M., van den Berg, H. W.
Publicado 1992

Proceedings: The kinetic response of HeLa cells to MAM acetate treatment.

por Bedford, A. J., Knowles, J. D., Kenny, T. E., Van den Berg, H. W.
Publicado 1974

Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen...

por van den Berg, H. W., Leahey, W. J., Lynch, M., Clarke, R., Nelson, J.
Publicado 1987

Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.

por McDermott, B. J., Van den Berg, H. W., Martin, W. M., Murphy, R. F.
Publicado 1983

Polarity and timing-dependent effects of transcranial direct current stimulation in explicit motor learning

por Stagg, C.J., Jayaram, G., Pastor, D., Kincses, Z.T., Matthews, P.M., Johansen-Berg, H.
Publicado 2011

Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormon...

por van den Berg, H. W., Claffie, D., Boylan, M., McKillen, J., Lynch, M., McKibben, B.
Publicado 1996

Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype.

por van den Berg, H. W., Lynch, M., Martin, J., Nelson, J., Dickson, G. R., Crockard, A. D.
Publicado 1989

Neurochemical Effects of Theta Burst Stimulation as Assessed by Magnetic Resonance Spectroscopy

por Stagg, C. J., Wylezinska, M., Matthews, P. M., Johansen-Berg, H., Jezzard, P., Rothwell, J. C., Bestmann, S.
Publicado 2009

Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry‐based study

por Jonker, Carla J., Oude Rengerink, Katrien, Hoes, Arno W., Mol, Peter G. M., van den Berg, H. Marijke
Publicado 2020

Registries supporting new drug applications

por Jonker, Carla J., van den Berg, H. Marijke, Kwa, Marcel S.G., Hoes, Arno W., Mol, Peter G.M.
Publicado 2017

Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders

por Jonker, Carla J., de Vries, Sieta T., van den Berg, H. Marijke, McGettigan, Patricia, Hoes, Arno W., Mol, Peter G. M.
Publicado 2021

Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients

por Fischer, Kathelijn, Pendu, Ronan, van Schooten, Carina J., van Dijk, Karin, Denis, Cécile V., van den Berg, H. Marijke, Lenting, Peter J.
Publicado 2009